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The ubiquitin-interacting motif (UIM) is a short pep-
tide motif with the dual function of binding ubiquitin
and promoting ubiquitylation. This motif is conserved
throughout eukaryotes and is present in numerous pro-
teins involved in a wide variety of cellular processes
including endocytosis, protein trafficking, and signal
transduction. We previously reported that the UIMs of
epsin were both necessary and sufficient for its ubiqui-
tylation. In this study, we found that many, but not all,
UIM-containing proteins were ubiquitylated. When ex-
pressed as chimeric fusion proteins, most UIMs pro-
moted ubiquitylation of the chimera. In contrast to pre-
vious studies, we found that UIMs do not exclusively
promote monoubiquitylation but rather a mixture of
mono-, multi-, and polyubiquitylation. However, UIM-
dependent polyubiquitylation does not lead to degrada-
tion of the modified protein. UIMs also bind polyubiq-
uitin chains of varying lengths and to different degrees,
and this activity is required for UIM-dependent ubiqui-
tylation. Mutational analysis of the UIM revealed spe-
cific amino acids that are important for both polyubiq-
uitin binding and ubiquitin conjugation. Finally we
provide evidence that UIM-dependent ubiquitylation in-
hibits the interaction of UIM-containing proteins with
other ubiquitylated cellular proteins. Our results sug-
gest a new model for the ubiquitylation of UIM-contain-
ing proteins.
The UIM1 was first described as a peptide sequence consist-
ing of a highly conserved -X-X-A-X-X-X-S-X-X-Ac core where
 represents a hydrophobic residue and Ac is an acidic residue
(1). It was identified based on the ubiquitin binding region of
the RPN10 subunit of the 26 S proteasome (2, 3). The presence
of UIMs in numerous proteins ranging from the Machado-
Joseph disease protein (MJD1/ataxin3) to USP25, a member of
the deubiquitylating enzyme family, suggests that this region
is involved in regulating protein function. Indeed our previous
studies and those of others have demonstrated an important
role for UIMs in both ubiquitylation and in ubiquitin binding
(2–11).
Ubiquitylation is a post-translational modification resulting
in the covalent attachment of ubiquitin through its COOH-
terminal Gly to the -NH2 group of a Lys residue in a target
protein. This process involves a multienzyme cascade that be-
gins with the activation of ubiquitin in the presence of ATP and
an E1 ubiquitin-activating enzyme. Subsequently the ubiquitin
is transferred through a thiol-ester bond to a ubiquitin-conju-
gating enzyme (E2) and through the action of an E3 ubiquitin
ligase is attached to the substrate by an isopeptide bond. Poly-
ubiquitylation, the attachment of multimeric chains of ubiq-
uitin, leads to the proteolytic destruction of proteins when
Lys48 of ubiquitin is the site of chain formation. However,
ubiquitin chains formed through Lys63 are not involved in
protein degradation but rather a variety of processes including
DNA repair, translation, IB kinase activation, endocytosis,
and protein transport (for a review, see Ref. 12). In contrast to
polyubiquitylation, some proteins are modified by the attach-
ment of a single ubiquitin, termed monoubiquitylation (13). A
variation on this process is the attachment of single ubiquitin
molecules to multiple lysines within a protein, hereafter re-
ferred to as multiubiquitylation. Although the precise function
of mono- and multiubiquitylation is still unclear, studies indi-
cate that these modifications are important for endocytosis,
transcriptional regulation, and trafficking of receptors to the
lysosome (for a review, see Ref. 12). Thus, the ubiquitylation
pathway controls protein function and cell fate in a number
of ways.
Although the precise function of UIM-directed ubiquitylation
is still unclear, a number of studies suggest that this modifi-
cation is physiologically important. Genetic studies of photo-
receptor development in Drosophila have identified an epsin
ortholog, termed Liquid facets (Lqf), as an important mediator
of photoreceptor cell fate (14) and also uncovered a role for a
deubiquitylating enzyme, Fat facets (Faf), in regulating Lqf
function. Loss-of-function mutations in Faf result in a pheno-
type similar to loss-of-function mutations in Lqf (14) and bio-
chemically result in Lqf polyubiquitylation and degradation
(15). However, in mammalian cells, epsin is not targeted
for polyubiquitylation and degradation but rather is mono-
ubiquitylated (8, 9). A recent study from DeCamilli and col-
leagues (16) provides compelling evidence for a rapid Ca2-de-
pendent deubiquitylation of epsin mediated by the mammalian
counterpart of Faf. This deubiquitylation restores the ability of
epsin to interact with phospholipid vesicles as well as compo-
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nents of the clathrin coat thereby providing the first direct
evidence for a physiological role for UIM-dependent ubiquity-
lation. Although less direct, genetic studies in yeast have dem-
onstrated that mutations in UIMs of proteins also lead to
defects in protein trafficking (10, 11). Although the phenotypes
of these mutations were ascribed to loss of ubiquitin binding by
the UIMs, these mutations would also block ubiquitylation of
the UIM proteins. Thus, the contribution of these two activities
of the UIMs, i.e. ubiquitylation and ubiquitin binding, cannot
be discerned from these experiments.
Given previous findings and the observation that UIMs are
present in a wide variety of proteins, we initiated studies of the
UIMs from numerous proteins to evaluate whether these mo-
tifs play a general role in ubiquitylation. In addition, we per-
formed a structure-function analysis to gain insight into the
mechanism of UIM-dependent ubiquitylation. The results pre-
sented here demonstrate that UIMs, in general, bind poly-
ubiquitin chains and promote ubiquitylation. Additionally
ubiquitylation of UIM proteins appears to inhibit their inter-
action with ubiquitylated targets. Finally our data suggest a
new mechanism for UIM-directed ubiquitylation.
MATERIALS AND METHODS
Cells and Reagents—Human embryonic kidney (293T) cells were
cultured as described previously (8). Antibodies used for these studies
include monoclonal anti-hemagglutinin (HA) (Babco); anti-glutathione
S-transferase (GST) conjugated to horseradish peroxidase (Santa Cruz
Biotechnology, Inc.); full-length A.V. polyclonal antibody, Living Colors
peptide antibody to GFP, and its variants (Clontech); monoclonal anti-
body against ubiquitin (Covance); and anti-FLAG M5 monoclonal anti-
body (Sigma).
Constructs—The pCGN-epsin, pKU-Hrs, and pMT3-MEKK1 con-
structs were described previously (8, 17, 18). pCGN-MJD was con-
structed by PCR amplification of A431 cDNA with 5MJDFULL
(GACGGATCCATGGAGTCCATCTTCCACGAGA) and 3MJDFULL
(GACGGATCCGATATCTTATTTTTTTCCTTCTGTTTT). The fragment
was subsequently digested with BamHI and EcoRV and subcloned into
the pCGN-Hyg expression vector (a gift of M. Ostrowski) digested with
NotI, blunt-ended with Klenow fragment, and then digested with
BamHI. pCGN-KIAA1386 was constructed by digesting pBluescript-
KIAA1386 (a gift of K. Nagase) with BglII and HpaI. The result-
ing fragment was subcloned into pCGN-Hyg digested with BamHI.
pCGN-HSJ1 was constructed by PCR amplification of HSJ1B (16) with
5HSJFULL (GACGGATCCATGGCATCCTACTACGAGATCCTA) and
3HSJFULL (GACGGATCCTCAGGATACTCCCCTCTTCTCTTCCCA),
digestion of the product with BamHI, and subcloning into pCGN-Hyg
digested with BamHI.
The following UIM constructs were constructed by PCR amplification
of A431 cDNA: Hrs UIM (aa 252–288) with 5HRS_UIM (GACGGAT-
CCAAGAGGGACGAGACGGCCCTG) and 3HRS_UIM (GACGATAT-
CAGTGTACGTGGACTTCTGTCT), USP25 UIM (aa 88–117) with
5USP_UIM (GACGGATCCGATACAAATGTGATTGATCTCA) and
3USP25_UIM (GACGATATCAATGGCTTGTTCCTCATCAGTT),
MJD1 UIM (aa 216–356) with 5MJDcorrect (GACGGATCCAATGAT-
GGCTCAGGAATGTT) and 3MJD_UIM (GACGATATCTGTTTTCAA-
ATCATTTCTGACA), RPN10 UIM (aa 203–329) with 5HS5_UIM (GA-
CGGATCCGACTTTGAATTTGGAGTAGAT) and 3HS5_UIM (GACG-
ATATCGGCATCAATGTCTGTGATT), KIAA1386 UIM (aa 974–1010)
with 5K1386_UIM (GACGGATCCTTGGATGAAGACGATCCCAAT-
ATA) and 3K1386_UIM (GACGATATCTAAGGATGCTTCATTACTG-
AGGAA), HSJ UIM (aa 235–294) with 5HSJ_UIM (GACGGATCCCA-
GGTCCAGCAGACCCCTGCCT) and 3HSJ_UIM (GACGATATCCT-
GGATCTTGGTGCTGGGCCTT), KIAA1594 UIM (aa 646–799) with
5K1594_UIM (GACAGATCTGAATTGGAAAACTCAGGATTT) and 3-
K1594_UIM (GACGATATCGGAGTTGTTAAACTCTTGAAGA), and
MEKK1 UIM (aa 1162–1186) with 5MEKK1_UIM (GACGGATCCAT-
GGAGGCTGAGGAAGAGGAGGCGCT) and 3MEKK1_UIM (GACGA-
TATCTATGGGGAGGGCGTCCTGAGAAGCCGA). Each resulting
product except KIAA1594 was digested with BamHI and EcoRV. The
KIAA1594 product was digested with BglII and EcoRV. The fragments
were then subcloned into pEFG (8) digested with BamHI and EcoRV,
pEYFP-C1 (Clontech) digested with BglII and SmaI, and pGEX (Am-
ersham Biosciences) digested with BamHI and EcoRV. GST-epsin
(UIM1–3) and GST-Eps15 (UIMwt) were described previously (8).
pGEX epsin, pGEX eps15, yellow fluorescent protein (YFP)-epsin, and
YFP-eps15 were made by digesting GST-epsin and GST-eps15 with
BamHI and SmaI and subcloning into pEYFP digested with BglII and
SmaI and pGEX digested with BamHI and EcoRV.
Mutant versions of Hrs and USP25 UIMs were created using Qiagen
multisite-directed mutagenesis kits with the following primers:
HrsL265R with HRSmutL-R (GAGGAGGAGCTGCAGCGGGCCCTGG-
CGCTGTC), USP25R104L with USPmutR-L (GATGATCTTCAGCTA-
GCAATTGCCTTG), USP25L110Q/A111S with USPmutLA-QS (AATT-
GCCTTGAGTCAGGCCGAATCAAACA), and Hrs Q271L/S272A with
HRSmutQS-LA (GCCCTGGCGCTGTCATTGGCAGAGGCGGAGGA).
Hrs triple mutant and USP25 triple mutant were created using both
corresponding primers. The pGEX versions of these constructs were
created by PCR amplifying the UIMs from the YFP mutated versions
using 5HRS_UIM, 3HRS_UIM, 5USP_UIM, and 3USP_UIM. Frag-
ments were then digested with BamHI and EcoRV and subcloned into
pGEX digested with BamHI and EcoRV.
The UIMs of Hrs, MJD, and RPN10 were PCR-amplified from the
YFP-UIM DNA using the 3 UIM primers from above and the following
5 primers: RPN10-YFP with 5S5a-YFP (GACAAGCTTACCACCATG-
GACTTTGAATTTGGAGTAGAT), Hrs-YFP with 5HRS-YFP (GACAA-
GCTTACCACCATGGACGAGACGGCCCTGCAGGA), and MJD-YFP
with 5MJD-YFP (GACAAGCTTACCACCATGGCAAATGATGGCTCA-
GGAAT). Each primer included the addition of a start site at the
beginning of the sequence. The resulting products were digested with
BamHI and EcoRV and subsequently subcloned into the pEFYP-N1
vector (Clontech) digested with BglII and SmaI.
The HA epitope-tagged ubiquitin expression construct pMT123 used
in the GST fusion protein experiments has been described previously
(19) and was kindly provided by Dr. Dirk Bohmann. For determining
the type of ubiquitylation and YFP fusion protein experiments, FLAG-
tagged ubiquitin was created by digesting the pcDNA3 HA-ubiquitin
construct kindly provided by Dr. Cam Patterson with BamHI and
EcoRI. The fragment was then subcloned into the pFLAG-CMV-2 vector
digested with SmaI and XbaI (Sigma). The UbK construct was created
by first mutating lysines 6, 11, 27, and 33 of the pCDNA3 HA-UbK29R/
K48R/K63R mutant construct kindly provided by Dr. Cam Patterson
using the Qiagen multisite-directed mutagenesis kit and the following
5 phosphorylated primers: Lysine 6, CAGATCTTCGTGAGGACCCT-
TACCGGC; Lysine 11, ACCCCTTACCGGCAGGACCATCACCCTT; Ly-
sine 27, CATCGAAAATGTGAGGGCCAGGATCCAGG, and Lysine 33,
CAAGATCCAGGATAGAGAAGGCATCCCTC. The construct was then
digested with NheI and EcoRV and subcloned into the pFLAG-CMV-2
vector digested with SmaI and XbaI. FLAG-UbI44A was created by
mutating isoleucine 44 to alanine of the pFLAG-CMV-2 Ub construct
using the Qiagen multisite-directed mutagenesis kit and the following
primer: UB I44A, CAGCAGAGGCTCGCGTTTGCAGGCAAG. All con-
structs were verified by DNA sequence analysis.
Ubiquitylation Assays—Assays were performed essentially as de-
scribed previously (8). Briefly HEK 293T cells were transiently trans-
fected with 2 g of HA-tagged epsin, MJD1, HSJ1, Hrs, KIAA1386, or
MEKK1 and 4 g of FLAG-tagged UbWT, UbK, or UbI44A. Fusion
proteins were purified from lysates (1 mg of protein) using HA affinity
beads (Affiniti). Precipitates were washed five times with PLC-LB as
described previously (8), fractionated by SDS-PAGE, and then trans-
ferred to Immobilon P membranes. Membranes were probed with either
anti-HA to detect expression of the full-length proteins or anti-FLAG to
detect ubiquitylation. Western blot analysis of 30–40 g of lysates
verified equal expression of the UbWT, UbK, and UbI44A.
Similarly HEK 293T cells were transiently transfected with 2 g of
various YFP constructs along with 4 g of FLAG-tagged UbWT, UbK,
or UbI44A. Lysates were immunoprecipitated with the full-length A.V.
polyclonal antibody (Clontech), fractionated by SDS-PAGE, and then
immunoblotted with anti-FLAG antibody to detect ubiquitylation. Ex-
pression of the YFP-UIM or UIM-YFP proteins was detected by immu-
noblotting with Living Colors peptide antibody (Clontech). The GST
pull-down experiments were done as described previously (8).
Treatment with harsher lysis conditions was done by adding 1⁄10
volume of 10% sodium deoxycholate and 1⁄100 volume of 10% SDS to the
lysate prior to immunoprecipitation. The immunoprecipitates were
then washed twice with PLC-LB supplemented with 1% sodium deoxy-
cholate and 0.1% SDS and twice with PLC-LB containing no sodium
deoxycholate or SDS.
Ubiquitin Binding Assays—The wild type or mutant GST-UIM con-
structs were expressed in Escherichia coli and purified using GSH
beads. The GST fusion proteins were diluted to 200 pmol/50 l of a 50%
slurry of the following lysis buffer: 25 mM HEPES, pH 7.2, 125 mM
potassium acetate, 2.5 mM magnesium acetate, 5 mM EGTA, 0.5%
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Triton X-100, 1 mM dithiothreitol plus protease inhibitors (as described
in Ref. 8) supplemented with 1 mg/ml bovine serum albumin. 50 l of
the GST proteins in 450 l of lysis buffer were mixed with 1 l of
ubiquitin or polyubiquitin ranging from two to seven ubiquitins (Af-
finiti) at a concentration of 0.25 g/l. Samples were incubated at 4 °C
for 2 h. Beads were pelleted and washed twice with 500 l of lysis buffer
without bovine serum albumin. Samples were fractionated on a gel and
detected via Gel Code© blue stain. Alternatively gels were transferred
to an Immobilon P filter and preincubated with denaturing buffer (6 M
guanidine HCl, 20 mM Tris-HCl, pH 7.5, 5 mM -mercaptoethanol, and
1 mM phenylmethylsulfonyl fluoride) as described in Ref. 20. After
washing extensively with phosphate-buffered saline, the filter was im-
mersed in 100% methanol for 5 min, placed on filter paper, dried for 15
min, and then probed with -ubiquitin.
RESULTS
Ubiquitylation of UIM-containing Proteins—To gain under-
standing into the function of UIMs in ubiquitylation and ubiq-
uitin binding, we evaluated the biochemical properties of UIMs
from a variety of proteins (Fig. 1). These proteins were chosen
based on their involvement in endocytosis, signal transduction
pathways, and various human diseases. RPN10 is a subunit of
the 26 S proteasome that specifically binds polyubiquitin
chains and was the founding member of the UIM family of
proteins (2, 3). Hrs is a tyrosine kinase receptor substrate that
has been implicated in the endocytosis of growth factor-recep-
tor complexes (21), while USP25 is thought to be a deubiqui-
tylating enzyme linked to Down syndrome (22). KIAA1386 and
KIAA1594 are uncharacterized proteins (23). Similar to
USP25, KIAA1594 contains two bipartite ubiquitin protease
catalytic domains suggesting it may function as a deubiquity-
lating enzyme. KIAA1386 contains three parkin-type complex
zinc finger domains and one parkin COOH-terminal domain
suggesting a link to Parkinson’s disease. HSJ1 is a neuron-
specific protein involved in clathrin uncoating (24), while
MJD1 is a polyglutamine tract protein that undergoes
expansion of its polyglutamine region leading to the neuro-
degenerative disorder Machado-Joseph disease (25). MEKK1 is
a Ser/Thr kinase involved in activation of the mitogen-acti-
vated protein kinase pathway and also contains a plant home-
odomain domain that functions as a non-canonical RING finger
E3 ligase (26, 27). Previous studies have shown that epsin,
Eps15/Eps15R, and Hrs are monoubiquitylated in a UIM-de-
pendent manner (6–9). We tested the possibility that UIM-
containing proteins in general might undergo a similar post-
translational modification. HA epitope-tagged MJD1, Hrs,
HSJ1, epsin, KIAA1386, or MEKK1 were transiently co-ex-
pressed in 293T HEK cells along with FLAG epitope-tagged
ubiquitin (UbWT). Western blot analysis of HA immunoprecipi-
FIG. 1. The UIM is present in numerous proteins with varying functions. These proteins range from endocytic adaptor proteins epsin and
Eps15 to USP25, a deubiquitylating enzyme linked to Down syndrome. UIMs are represented by red ovals. Each UIM consists of a conserved core
sequence, XeeeXXXAXXXSXXe where e is a negatively charged residue,  is a hydrophobic residue, and X is any amino acid. Conserved residues
are highlighted in yellow. Sequences conserved in 50% of the UIMs as described by Hoffman and Falquet (1) are highlighted in red. Note that
the UIMs in MEKK1 are overlapping. Ank, ankyrin repeat region; EH, Eps15 homology domain; ENTH, epsin NH2-terminal homology domain;
FYVE, FYVE finger domain; J, dnaJ chaperone domain; KINASE, protein kinase catalytic domain; P-CT, parkin COOH-terminal domain; PF1–3,
parkin-type complex zinc finger domains 1–3; Poly-Q, polyglutamine repeat region; UBA, ubiquitin-associated domain; UBP, bipartite ubiquitin
protease catalytic domain; VHS, Vps27-HRS-Stam domain; VWA, von Willebrand factor type A domain; PHD, plant homeodomain.
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tates revealed that all the full-length proteins were expressed
at similar but not identical levels (Fig. 2A, bottom panel). In
addition, there were slower migrating HA-reactive bands in the
Hrs and MJD1 samples that were shifted by 13-kDa incre-
ments consistent with the attachment of FLAG ubiquitin. In-
deed these shifted forms reacted with antibodies to tagged
ubiquitin (Fig. 2A, top panel). In the case of MJD1, the first
shifted band in the HA Western blot did not react with anti-
bodies to FLAG ubiquitin indicating that the altered mobility
was not due to ubiquitylation. Although MEKK1 did react with
-FLAG antibody indicating it was ubiquitylated, it was not
possible to resolve a molecular weight shift due to the size of
MEKK1. In contrast, KIAA1386 was not ubiquitylated. Multi-
ple shifted forms of MJD1, Hrs, epsin, HSJ1, and MEKK1
were detected with antibodies to FLAG-ubiquitin suggesting
that these UIMs promoted polyubiquitylation. To determine
whether these higher molecular weight forms represented
polyubiquitylation, multiubiquitylation, or a combination of
these two possibilities, the HA-tagged full-length proteins were
transiently co-expressed with FLAG epitope-tagged ubiquitin
devoid of Lys (Ub) and thus no longer capable of forming
chains. Ubiquitylation of the full-length proteins was decreased
in cells expressing UbK indicating that epsin and Hrs as well
as MJD1, MEKK1, and HSJ1 were at least partially polyubiq-
uitylated. Longer exposures uncovered shifted bands with the
expression of UbK suggesting that these proteins may also be
modified by the attachment of multiple monoubiquitins (Fig. 2
and data not shown). Furthermore a decrease in the level of
monoubiquitylation of several of these proteins was observed
with the Ub as compared with UbWT suggesting that polyu-
biquitin chains are required for monoubiquitylation. These dif-
ferences in ubiquitylation were not due to differences in the
steady state levels of the mono-UbWT and mono-UbK as both
were expressed equally (Fig. 2C). Treatment of cells with pro-
teasome inhibitor (MG132) did not alter the levels of the ubiq-
uitylated or non-ubiquitylated UIM-containing proteins (data
not shown) consistent with previous studies (6–9).
Our analysis of the UIM-containing proteins also indicated
that these proteins associated with ubiquitylated cellular pro-
teins consistent with a role for the UIMs in binding ubiquitin
(Supplemental Fig. 1). These high molecular weight FLAG-
reactive bands corresponded to ubiquitylated cellular proteins
rather than polyubiquitylated UIM proteins since their pres-
ence was dramatically reduced by the inclusion of SDS and
deoxycholate in the lysis buffer (Fig. 2 and Supplementary
Fig. 1). Furthermore these high molecular weight FLAG-reac-
FIG. 2. Ubiquitylation of the full-length proteins. A, full-length HA-epitope tagged UIM-containing proteins were co-expressed with either
FLAG-tagged wild type ubiquitin (WT) or ubiquitin with all lysines mutated to arginines (K) in 293T HEK cells. Following immunoprecipitation
with HA affinity beads in the presence of SDS and deoxycholate, proteins were fractionated on gels, transferred to Immobilon P filters, and probed
with either -FLAG (top) or -HA (bottom). *, longer exposures (B) revealed ubiquitylation of epsin and HSJ1 in both lanes, although the levels
were lower in the UbK samples. Although the levels of UbWT and UbK expression were equivalent with a given protein, the expression of these
two vary between the different UIM proteins. C, to verify equal expression and lack of ubiquitin chain formation by the mutant ubiquitin,
FLAG-UbWT and -UbK were expressed in 293T cells, and equivalent amounts of cell lysates were analyzed by Western blot using the FLAG
antibody.
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tive bands were not visible on longer exposure of the HA West-
ern blot of the HA immunoprecipitates (data not shown).
UIMs of Various Proteins Are Sufficient to Promote Ubiqui-
tylation of a Chimeric Fusion Protein—To determine whether
the isolated UIMs of the aforementioned proteins promoted
ubiquitylation, YFP-UIM chimeras were expressed in 293T
cells along with FLAG-tagged ubiquitin. Western blot analysis
demonstrated UIM-dependent ubiquitylation of these heterol-
ogous fusion proteins to varying degrees with the highest level
by Eps15 and Hrs and the lowest level by USP25 and HSJ1
(Fig. 3). The MEKK1 UIM exhibited no ubiquitylation activity,
although full-length MEKK1 was highly ubiquitylated (Fig. 2).
With several of the YFP-UIM fusion proteins, we detected a
ladder of ubiquitin conjugates. As with the full-length proteins
in Fig. 2, co-expression of Ub resulted in a dramatic reduc-
tion in these ladders indicating that the proteins were poly-
ubiquitylated. Longer exposures revealed multiple shifted
forms with the Ub indicating that a portion of these shifted
bands resulted from the attachment of multiple monoubiqui-
tins. Furthermore expression of UbK also resulted in reduc-
tion in the monoubiquitylated form of the YFP chimeras simi-
lar to results with the full-length proteins. Treatment with
MG132 did not alter the levels of either the unmodified or
ubiquitylated fusion proteins (data not shown). The YFP-UIM
proteins associated with ubiquitylated cellular proteins as ev-
idenced by a high molecular weight smear of proteins that
reacted with the FLAG antibody and were dramatically re-
duced when SDS and deoxycholate were included in the lysis
buffer (Fig. 3 and Supplementary Fig. 2).
To address whether the UIM was the site of ubiquitylation,
GST-tagged versions of the isolated UIMs were co-expressed
along with HA-Ub in 293T HEK cells as described previously
(8). Many of the GST chimeric fusion proteins were ubiquityl-
ated but to varying degrees similar to the YFP-UIM fusion
proteins (Supplementary Fig. 3). Purification of the GST fusion
proteins from cells followed by thrombin cleavage revealed that
the GST and not the UIM portion of the fusion protein was the
site of ubiquitin attachment even though a number of these
UIMs contain lysine residues (Supplemental Fig. 3). However,
in the case of KIAA1594, we detected ubiquitylation of the UIM
portion of the fusion protein suggesting that one or more of the
lysines present in the region between the UIMs may function
as ubiquitylation sites.
UIM-dependent Ubiquitylation Occurs in an Orientation-de-
pendent Manner—Our previous results with epsin suggested
that ubiquitylation occurs within the epsin NH2-terminal ho-
mology domain (8). Given the preponderance of UIMs in the
central and COOH terminus of proteins (1), we tested the
possibility that UIMs promoted ubiquitylation in an orienta-
tion-specific manner. YFP was fused to either the NH2 termi-
nus or COOH terminus of the UIMs of Hrs, RPN10, and MJD
and then co-expressed with epitope-tagged ubiquitin. As seen
previously, the YFP-UIM proteins (N1 and N2) were ubiquityl-
ated; however, the UIM-YFP fusion proteins (C1 and C2) were
significantly reduced in their ubiquitylation even though both
forms of the proteins were expressed equally (Fig. 4). In addi-
tion, the UIM-YFP chimeric proteins all bound to high molec-
ular weight ubiquitylated proteins to a greater extent than
the YFP-UIM proteins. Lysis of cells in buffer containing 0.1%
SDS and 1% sodium deoxycholate dramatically reduced levels
of these high molecular weight bands without affecting the
level of the YFP fusion proteins. Thus, these proteins repre-
sent ubiquitylated UIM-associated proteins and not poly-
ubiquitylated forms of the YFP fusion protein.
Mutational Analysis of the UIM—Given the differences in
ubiquitylation between UIMs, we tested whether specific
FIG. 3. The isolated UIMs are sufficient to promote ubiquitylation of a chimeric YFP fusion protein. The YFP-UIM constructs or YFP
alone were co-expressed with FLAG-tagged UbWT or UbK in 293T HEK cells. Following immunoprecipitation with GFP antibody in the presence
of SDS and deoxycholate, proteins were fractionated on gels, transferred to Immobilon P filters and probed with -FLAG (top) or -GFP (bottom).
*, longer exposures (data not shown) revealed ubiquitylation of epsin, HSJ1, and USP25 in both lanes, although the levels were lower in the UbK
samples. ** represents a contaminating band. Expression of UbWT and UbK were the same as in Fig. 2.
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amino acid mutations might alter ubiquitylation efficiency by a
particular UIM. Hrs and USP25 were chosen for comparison
because each contains a single UIM, and they are representa-
tive of the range of ubiquitylation promoted by the various
UIMs. Sequence comparison revealed two significant differ-
ences between the UIMs from Hrs and USP25 that might
influence UIM function: a leucine versus arginine (amino acid
265 of Hrs) and glutamine-serine versus leucine-alanine (amino
acids 271 and 272 of Hrs) (Fig. 1). We mutated these regions
either alone or in combination to determine their importance
for UIM function. YFP fusions of either wild type or mutant
Hrs and USP25 UIMs were co-expressed in 293T cells along
with UbWT. HrsL265R was impaired in ubiquitylation (94%
decrease relative to Hrs wild type), while the corresponding
mutation in USP25 (R104L) enhanced ubiquitylation by more
than 7-fold as compared with the wild type USP25 UIM (Fig.
5). In contrast, ubiquitylation of Hrs Q271L/S272A was similar
to wild type Hrs. The Hrs triple mutant demonstrated a 49%
decrease in ubiquitylation, whereas USP25L110Q/A111S and
USP25 triple mutants demonstrated no ubiquitylation. Thus,
the choice of amino acid at these three positions plays an
important role in dictating whether a UIM will promote
ubiquitylation.
Ubiquitin Binding by the UIM—Although the UIM promotes
ubiquitylation, several groups have demonstrated that UIMs
bind ubiquitin (2–4, 9–11, 28, 29). In addition, ubiquitin binding
activity appears necessary for the ability of yeast epsins ENT1p
and ENT2p to promote receptor internalization (11). Using an in
vitro ubiquitin binding assay, we found that most UIMs bound
polyubiquitin chains to varying degrees (Fig. 6A). In contrast, the
MEKK1 UIM did not bind polyubiquitin. As with the ubiquityl-
ation assays, the ability to bind polyubiquitin did not correlate
with the number of UIMs present in the protein. In addition,
different UIMs exhibited preferences for different length
ubiquitin chains (Table I). We did not observe detectable binding
of any UIM to monoubiquitin (data not shown), although others
have reported low affinity binding (9, 10, 30). Thus, UIMs appear
to preferentially bind polyubiquitin chains versus monoubiquitin.
This selectivity was not due to an additive effect since there was
selectivity in the recognition of different length ubiquitin chains
by particular UIMs (see Table I).
The dual role for the UIM in binding ubiquitin and promot-
ing ubiquitylation prompted us to test whether mutations that
affected ubiquitylation also affected ubiquitin binding. GST
fusion proteins of the Hrs and USP25 UIM mutants described
above were purified and used in an in vitro ubiquitin binding
assay as described above. Quantitation of the binding data
indicated that the same mutations that altered ubiquityla-
tion of the YFP-UIM proteins also altered polyubiquitin bind-
ing (Fig. 6, B and C). The HrsL265R mutation dramatically
decreased polyubiquitin binding by 88%. Conversely the
USP25R104L mutant had a 2–3-fold increase in poly-
ubiquitin binding relative to the wild type UIM. Similar to
their ubiquitylation properties, USP25L110Q/A111S and
USP25 triple mutants possessed very weak polyubiquitin
binding activity. Indeed of six experiments only one resulted
in any measurable binding. In contrast to their ubiquityla-
tion pattern, Hrs Q271L/S272A exhibited a 2-fold binding
increase, whereas the Hrs triple mutant showed binding
similar to the WT Hrs.
Ubiquitin Binding Is Necessary for UIM-dependent Ubiqui-
tylation—The ubiquitin binding properties of the mutant UIMs
suggested that polyubiquitin binding may be necessary for
UIM-dependent ubiquitylation. To address this question, we
tested whether the UIMs were able to promote ubiquitylation
when co-expressed with a mutant ubiquitin (I44A) no longer
capable of binding to ubiquitin binding domains such as CUEs
and UIMs (11, 31–33). Co-expression of either WT or I44A
ubiquitin along with full-length proteins demonstrated that
ubiquitin binding is important for ubiquitylation of UIM-con-
taining proteins (Fig. 7). In contrast to previous experiments,
we did not include SDS and deoxycholate in the lysis buffer so
that we could examine both ubiquitylation of the UIM proteins
as well as binding to ubiquitylated proteins by the UIM pro-
teins. As with the full-length proteins, ubiquitylation of the
chimeric YFP-UIM proteins was also dramatically decreased in
the I44A ubiquitin-expressing cells suggesting that ubiquitin
binding is necessary for UIM-directed ubiquitylation. As ex-
pected, the expression of I44A ubiquitin also resulted in a
decreased association of the UIM proteins with ubiquitylated
proteins (Fig. 7). These results were not due to differential
FIG. 4. Isolated UIMs promote ubiq-
uitylation in an orientation-depend-
ent manner. The isolated UIMs from
Hrs, RPN10, or MJD were fused with
YFP as either NH2-terminal or COOH-
terminal chimeras and then co-expressed
with UbWT into 293T cells. Following im-
munoprecipitation with anti-GFP, the
proteins were fractionated on gels, trans-
ferred to Immobilon P filters, and probed
with -GFP (bottom) or -FLAG (top). To
distinguish between ubiquitylation of
UIM proteins versus the association of
ubiquitylated proteins, lysis buffer lack-
ing (1) or supplemented with (2) 0.1%
SDS and 1% sodium deoxycholate was
used.
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expression of WT or I44A ubiquitin as both were expressed
equally (data not shown).
DISCUSSION
Recent studies have revealed an important role for UIMs in
the monoubiquitylation of epsin, Hrs, and Eps15/Eps15R and
in the binding of ubiquitin and ubiquitin-like proteins (2–11).
Our current study characterized the activities of a panel of
UIMs from diverse proteins to determine the sequence and
structural requirements for their function. We have found that
many but not all UIM-containing proteins are ubiquitylated to
varying degrees and that the UIMs promote this modification.
In addition to Eps15, Hrs, and epsin, we found that MJD1,
MEKK1, and HSJ1 are ubiquitylated. However, our results
with MEKK1 suggest that its UIMs are not functional: they
neither bind ubiquitin nor promote ubiquitylation. Since
MEKK1 possesses an E3 ligase domain in addition to its kinase
domain, mutation or deletion of the UIMs will be necessary to
determine whether these motifs play any role in the ability of
MEKK1 to self-ubiquitylate.
In contrast to previous studies on UIM-dependent ubiquityl-
ation, we found that UIMs promoted polyubiquitylation in ad-
dition to monoubiquitylation. A number of UIMs promoted
polyubiquitylation of GST and YFP chimeric proteins (Ref. 8,
and Fig. 3 and Supplementary Figs. 1–3). Indeed full-length
epsin, Hrs, and MJD1 are modified by the attachment of mul-
tiple ubiquitins. These shifted forms were dramatically de-
creased upon expression of ubiquitin lacking all its lysines
(Ub). Since the levels of these polyubiquitylated species
were unaffected by inhibition of the proteasome, we predict
that this modification alters the function of these proteins
rather than targeting them for degradation. Several studies
have indicated that the UIMs are important for endocytosis
and sorting of ubiquitylated receptors and cargo proteins (6, 10,
11, 34). However, all of these studies utilized UIM mutations
that would simultaneously block ubiquitin binding as well as
ubiquitylation thus making it impossible to determine whether
the observed effects were due to one or both of these activities.
Once the site of ubiquitylation has been identified in these
proteins and mutants have been constructed it will then be
possible to assess whether this modification does indeed
alter function.
Expression of a ubiquitin mutant lacking lysines for conju-
gation (UbK) resulted in a significant reduction in the levels
of monoubiquitylated epsin, Hrs, and MJD1 suggesting that
polyubiquitin chains are necessary for monoubiquitylation of
these proteins. Since free polyubiquitin chains are present in
vivo (35), it is possible that these chains are used for ubiquityl-
ation of UIM proteins. This hypothesis is consistent with our
observation that UIMs preferentially recognize polyubiquitin
versus monoubiquitin and that polyubiquitin binding corre-
lates with ubiquitylation (see below). Through a process anal-
ogous to glycosylation, we propose that UIM-containing pro-
teins recruit free polyubiquitin chains through their UIMs
leading to the ligation of these chains en bloc to a specific
lysine(s) followed by trimming of the chains to a specific length
by a deubiquitylating enzyme. Consistent with this idea, ge-
netic and biochemical experiments suggest that epsin is regu-
lated in part by the deubiquitylating enzyme Faf (14, 16),
mutation of which increases the levels of polyubiquitylated
epsin leading to an overall decrease in epsin due to proteasomal
degradation (15). However, epsin does not appear to be regu-
lated by proteasomal degradation in mammalian cells (8, 9).
We speculate that in vivo epsin is transiently polyubiquitylated
but is spared from degradation through rapid processing of
the polyubiquitin chain by Faf leaving predominantly mono-
ubiquitylated epsin, which has a specific function in the cell.
That we do not observe any effect of MG132 on epsin or ubiq-
uitylated epsin levels may be due to high levels of Faf expres-
FIG. 5. Non-conserved amino acids within the UIM determine the efficiency of ubiquitylation. A, wild type and mutant Hrs and USP25
UIMs fused to the COOH terminus of YFP were co-expressed with UbWT in 293T HEK cells. Following immunoprecipitation with anti-GFP
antibodies in the presence of SDS and deoxycholate, proteins were analyzed by Western blot with -FLAG (top) or -GFP (bottom) antibodies. B,
the amount of ubiquitylation was quantitated by NIH Image analysis and then standardized to the amount of total YFP-UIM and ubiquitin in the
lysates. The data in the graph represent the ratio between Hrs WT and the other UIMs S.E. from three independent experiments. The level of
ubiquitin expression was equivalent between cell samples. Statistical significance was determined using Student’s t test. * represents p values
0.05 when compared with WT Hrs. ** represents p values 0.05 when compared with WT USP25. L-R, L265R; QS-LA, Q271L/S272A; R-L,
R104L; LA-QS, L110Q/A111S; Triple, all three mutations.
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sion in 293 cells,2 which may prevent the stable attachment of
ubiquitin chains of sufficient length to target epsin to the
proteasome. This idea reconciles the discrepant observations
concerning epsin ubiquitylation in Drosophila versus mamma-
lian cells, i.e. in Faf mutants, polyubiquitylated epsin would
accumulate and thus be shunted toward degradation, whereas in
mammalian cells, polyubiquitylated epsin would normally be
rapidly processed and thus refractory to proteasomal degrada-
tion. Furthermore this model provides for multiple levels of epsin
regulation thereby allowing for combinatorial control of epsin
function.
The ability of UIMs to promote ubiquitylation as well as to
bind ubiquitin is dependent on the sequence of the UIMs rather
than the absolute number of UIMs in a given protein. The core
UIM sequence of eeeXXXAXXXSXXe (where e is a negatively
charged residue,  is a hydrophobic residue, and X is any
amino acid) as proposed by Hofmann and Falquet (1) and
extended by Swanson et al. (36) contains three highly con-
served positions and four less well conserved negatively
charged amino acids. Recent x-ray crystallographic and NMR
structures of UIMs have revealed that the majority of these
conserved residues lie at the interaction surface between the
UIM and ubiquitin (or ubiquitin-like domain) (30, 36, 37). In-
deed mutation of these conserved residues alters ubiquitin
binding and ubiquitylation (6, 9–11, 30, 36, 37). Comparison of2 S. A. Wood, personal communication.
FIG. 6. Polyubiquitin binding varies between UIMs and is dependent on non-conserved sequences within the UIM. A, bacterially
expressed GST-UIMs (	200 pmol) were incubated with 0.25 g of polyubiquitin chains ranging from two to seven ubiquitins (Affiniti) for 2 h.
Proteins were fractionated on gels and stained with Gel Code blue for detection of GST proteins (bottom) or transferred to a membrane and probed
with -ubiquitin (top). A sample of the input ubiquitin chains used in these experiments is shown in B on the right. B, GST fusions of wild type
and mutant UIMs from Hrs or USP25 were tested for binding polyubiquitin chains in vitro. Western blots of bound ubiquitin chains were probed
with -ubiquitin (top). Protein gels were stained with Gel Code blue (bottom) to demonstrate input levels of the GST fusion proteins. The relative
amount of each ubiquitin chain is indicated in the Western blot of the input ubiquitin on the right. C, ubiquitin binding was quantitated by NIH
Image analysis and then standardized to the amount of total GST-UIM. The data in the graph represent the ratio between Hrs WT and the other
UIMs S.E. from six independent experiments (five experiments for Hrs triple mutant). Statistical significance was determined using Student’s
t test. * represents p values 0.05 when compared with WT Hrs. ** represents p values 0.05 when compared with WT USP25. L-R, L265R;
QS-LA, Q271L/S272A; R-L, R104L; LA-QS, L110Q/A111S; Triple, all three mutations.
TABLE I
UIMs demonstrate selectivity for polyubiquitin chains
of varying lengths
Qualitative analysis of the binding of different length ubiquitin
chains by UIMs. The levels of ubiquitin binding are represented by the
following: 
, no binding; 
/, weak binding; , low binding; ,
moderate binding; , high binding.
















    
KIAA1594 
     
MJD 
 
    
RPN10 

















Biochemical and Molecular Characterization of UIMs 33535
the single UIMs of Hrs and USP25, which have dramatically
different activities in binding ubiquitin and promoting ubiqui-
tylation, revealed two areas that contribute to these different
activities (Fig. 1). The presence of a hydrophobic residue in the
seventh position greatly enhanced both ubiquitin binding (3–5-
fold) and ubiquitylation (10–20-fold) (Figs. 5 and 6, compare Hrs
WT to L265R and USP25 WT to R104L). Examination of the UIM
structures in complex with ubiquitin do not provide immediate
insight into these effects given that this amino acid is on the
helical face of the UIM opposite the ubiquitin binding interface.
However, the comparable residue in the second UIM of RPN10
(Tyr289) exhibited several interactions with amino acids in the
ubiquitin-like domain of HHR23 suggesting that this residue
does indeed contribute to ligand binding (37). Given the selectiv-
ity of UIMs for polyubiquitin chains, it is possible that this amino
acid provides additional contacts with a second ubiquitin in a
chain thereby stabilizing the overall interaction. Positions 13 and
14 of the UIM have been predicted to be an important affinity
determinant, and indeed our mutational data support this pre-
diction (36). Both ubiquitin binding and ubiquitylation are in-
creased by the presence of aliphatic residues in these positions.
The analysis of the triple mutants in Hrs and USP25 are
more difficult to interpret. Based on the results with mutations
in position 7 or 13 and 14 of the UIM, we predicted that the
activities of the Hrs triple mutant would more closely resemble
those of the wild type UIM from USP25. Conversely we pre-
dicted that the activities of the USP25 triple mutant would
resemble those of the wild type UIM from Hrs. Our results did
not support those predictions and thus lead us to suggest that
residues outside the core UIM sequence may also influence the
activities of these UIMs, a possibility consistent with the re-
sults of Fisher and colleagues (30).
Several lines of evidence indicate that ubiquitin binding is an
important prerequisite for UIM-directed ubiquitylation. The
Hrs and USP25 mutants revealed quantitative changes in
ubiquitylation that directly correlated with effects on polyubiq-
uitin binding. Additionally expression of the ubiquitin I44A
mutant, which is impaired in its ability to bind ubiquitin-
associated, CUE, and UIM domains (for a review, see Ref. 38),
is not permissive for UIM-directed ubiquitylation (Fig. 7). Al-
though this mutant ubiquitin still forms polyubiquitin chains
(31), its expression decreased ubiquitylation of UIM proteins.
It is unclear, however, whether the UIMs are required to
FIG. 7. Ubiquitin binding by the UIM is necessary for UIM-dependent ubiquitylation. A, HA epitope-tagged full-length proteins were
co-expressed with FLAG-tagged UbWT (W) or UbI44A (I) in 293T HEK cells. Following immunoprecipitation with HA affinity beads in the absence
of SDS and deoxycholate, the proteins were fractionated on a gel and probed with -HA (bottom) or -FLAG (top). B, similarly YFP-UIM constructs
or YFP alone was co-transfected with UbWT or UbI44A. Lysates were then immunoprecipitated with the GFP antibody, fractionated on a gel, and
probed with either -GFP (bottom) or -FLAG (top). *, longer exposure revealed ubiquitylation of these proteins was decreased by expression of
UbI44 compared with UbWT (data not shown). C, lysates of cells expressing either FLAG-tagged wild type ubiquitin or ubiquitin I44A were
probed with anti-FLAG antibodies to demonstrate equal levels of expression of the monomeric forms of both proteins. In addition, ubiquitin
conjugates are present in both samples.
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bind free ubiquitin chains or ubiquitin attached to E2s and/or
E3s, although these two possibilities are not mutually exclu-
sive. We have found that the UIMs of epsin recruit an E3 ligase
complex leading to epsin ubiquitylation.3 Since epsin has three
UIMs, a subset of these may bind ubiquitin directly, while the
remaining UIM(s) recruit the E2-E3 complex. This separation
of functionality in multi-UIM proteins has been observed with
Eps15 in which the first UIM is important for ubiquitylation
but not ubiquitin binding, whereas the second UIM is impor-
tant for both functions (9).
Previous studies have found that the UIMs from epsin,
Eps15, and Hrs bind monoubiquitin with dissociation con-
stants in the range of 150–300 M (Ref. 30 and references
therein). Although we were unable to detect interaction of
UIMs with monoubiquitin, we did observe robust binding of
polyubiquitin chains by most UIMs (Fig. 6). The higher affinity
for polyubiquitin chains does not appear to be due to a cooper-
ative effect from having multiple ubiquitins present in a chain
since we observed that the affinity of UIMs for different length
ubiquitin chains did not correlate with chain length (Fig. 5 and
Table I). For example, the UIMs from Eps15 and KIAA1386
bound Ub3, Ub5, and Ub6 chains with little binding to Ub4.
These observations suggest that a particular UIM discrimi-
nates between different length ubiquitin chains and that a
longer chain does not necessarily confer increased binding.
Given that ubiquitin chains adopt different conformations (39,
40), UIMs may select one conformation over another. This
property may also dictate the specificity of interaction with
various ubiquitylated proteins in vivo.
While it is clear that UIM-containing proteins as well as
those with CUE domains are ubiquitylated, the role for this
modification remains elusive. It has been proposed that ubiq-
uitin and ubiquitin binding domains such as UIMs and CUEs
may be comparable to tyrosine phosphorylation and Src homol-
ogy 2 domains in that ubiquitylation may serve to regulate a
network of protein-protein interactions (41). Our data support
this notion. Results from this study as well as our previous
work on epsin (8) demonstrate that the UIMs promote ubiqui-
tylation of sites NH2-terminal to the UIM. Furthermore UIM-
YFP proteins associated with polyubiquitylated proteins more
avidly than YFP-UIM proteins. This result suggests that UIM
interactions with ubiquitylated cellular proteins are regulated
through an intramolecular interaction in which the UIM binds
to the ubiquitylation site in the UIM protein leading to a
conformational change that blocks the interaction with exoge-
nous ubiquitylated proteins. In the case of epsin, ubiquitylation
inhibits the association with liposomes, clathrin, and AP2 (16).
Although many proteins possess UIMs in the central or COOH-
terminal portions of their sequence, examination of the SMART
data base (42) revealed several uncharacterized proteins with
UIMs located at the extreme NH2 terminus. Based on our
findings and given the absence of Lys acceptor sites NH2-
terminal to the UIMs in these proteins, we predict that these
UIMs will function primarily to bind polyubiquitylated sub-
strates and not to promote ubiquitylation.
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